참고문헌
- Alvarez, R.D., J. Gomez-Navarro, M. Wang, M.N. Barnes, T.V. Strong, R.B. Arani, W. Arafat, J.V. Hughes, G.P. Seigal, and D.T. Curiel. 2000. Adenoviral-mediated suicide gene therapy for ovarian cancer. Mol. Ther. 2, 524-530. https://doi.org/10.1006/mthe.2000.0194
- Bergelson, J.M., A. Krithivas, L. Celi, G. Droguett, M.S. Horwitz, T. Wickham, R.L. Crowell, and R.W. Finberg. 1998. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J. Virol. 72, 415-419.
- Birchmeier, C. and K.A. Nave. 2008. Neuregulin-1, a key axonal signal that drives Schwann cell grwoth and differentiation. Glia 56, 1491-1497. https://doi.org/10.1002/glia.20753
- Bubill, E.M. and Y. Yarden. 2007. The EGF receptor family: spearheading a merger of signaling and therapeutics. Curr. Opin. Cell. Biol. 19, 124-134. https://doi.org/10.1016/j.ceb.2007.02.008
- Chen, W., R. Bardhan, M. Bartels, C. Perez-Torres, R. Pautler, N. Halas, and A. Joshi. 2010. A molecularly targeted theranostic probe for ovarian cancer. Mol. Cancer Ther. 9, 1028-1038. https://doi.org/10.1158/1535-7163.MCT-09-0829
- Dimova, I., B. Zaharieva, S. Raitcheva, R. Dimitrov, N. Doganov, and D. Toncheva. 2006. Tissue microarray analysis of EGFR and erbB2 copy number changes in ovarian tumors. Int. J. Gynecol. Cancer 16, 145-151. https://doi.org/10.1111/j.1525-1438.2006.00286.x
- Hong, J.S. and J.A. Engler. 1991. The amino terminus of the adenovirus fiber protein encodes the nuclear localization signal. Virol. 185, 758-767. https://doi.org/10.1016/0042-6822(91)90547-O
-
$H{\phi}gdall$ , E.V., L. Christensen, K.S. Kjaer, J. Blaakaer, J.E. Bock, E. Glud, B.$N{\phi}rgaard$ -Pedersen, and C.K.$H{\phi}gdall$ . 2003. Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma. Cancer Cell 98, 66-73. https://doi.org/10.1002/cncr.11476 - Hynes, N.E. and H. Lane. 2005. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 5, 341-354. https://doi.org/10.1038/nrc1609
- Ingram, N., L.P. MacCormac, N.T. Oxley, P.A. Burns, and G.D. Hall. 2010. Role of cell surface molecules and autologous ascitic fluid in determining efficiency of adenoviral transduction of ovarian cancer cells. Cancer Gene Ther. 17, 684-693. https://doi.org/10.1038/cgt.2010.24
- Jemal, A., R. Siegel, J. Xu, and E. Ward. 2010. Cancer statistics, 2010. CA Cancer J. Clin. 60, 277-300. https://doi.org/10.3322/caac.20073
- Jones, J.T., R.W. Akita, and M.X. Sliwkowski. 1999. Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett. 447, 227-231. https://doi.org/10.1016/S0014-5793(99)00283-5
-
Jones, J.T., M.D. Ballinger, P.I. Pisacane, J.A. Lofgren, V.D. Fitzpatrick, W.J. Fairbrother, J.A. Wells, and M.X. Sliwkowski. 1998. Binding interaction of the heregulin
$\beta$ egf domain with ErbB3 and ErbB4 receptors assessed by alanine scanning mutagenesis. J. Biol. Chem. 273, 11667-11674. https://doi.org/10.1074/jbc.273.19.11667 - Joung, I., G. Harber, K.M. Gerecke, S.L. Carroll, J.F. Collawn, and J.A. Engler. 2005. Improved gene delivery into neuroglial cells using a fiber-modified adenovirus vector. Biochem. Biophy. Res. Commun. 328, 1182-1187. https://doi.org/10.1016/j.bbrc.2005.01.080
- Joung, I., H.S. Kim, J.S. Hong, H. Kwon, and Y.K. Kwon. 2000. Effective gene transfer into regeneration sciatic nerves by adenoviral vector: Potentials for gene therapy of peripheral nerve injury. Mol. Cells 10, 540-545. https://doi.org/10.1007/s10059-000-0540-4
- Kim, J., E.S. Hwang, J.S. Kim, E. You, S.H. Lee, and J. Lee. 1999. Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouse FREE. Cancer Gene Ther. 6, 172-178. https://doi.org/10.1038/sj.cgt.7700006
- Korean Cancer database center. 2007. Death rate cause by cancers among Korean. Cancer Statistics.
- Lee, B.C., K. Cha, S. Avraham, and H.K. Avraham. 2004. Microarray analysis of differentially expressed genes associated with human ovarian cancer. Int. J. Oncol. 24, 847-851.
- McGuire, W.P. and M. Markman. 2003. Primary ovarian cancer chemotherapy: Current standards of care. Br. J. Cancer 89, 3-8.
- Morrison, J., S.S. Briggs, N.K. Green, C. Thoma, K.D. Fisher, S. Kehoe, and L.W. Seymour. 2009. Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer. Human Gene Ther. 20, 239-251. https://doi.org/10.1089/hum.2008.167
- Motoyama, A.B., N.E. Hynes, and H.A. Lane. 2002. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the ability of epidermal growth factor-related peptides. Cancer Res. 62, 3151-3158.
- Tanner, B., D. Hasenclever, K. Stern, W. Schormann, M. Bezler, M. Hermes, M. Brulport, A. Bauer, I.B. Schiffer, S. Gebhard, and et al. 2006. ErbB-3 predicts survival in ovarian cancer. J. Clin. Oncol. 24, 4317-4323. https://doi.org/10.1200/JCO.2005.04.8397
- Wickham, T.J. 2000. Targeting adenovirus. Gene Ther. 7, 110-114. https://doi.org/10.1038/sj.gt.3301115
- Zeimet, A.G. and C. Marth. 2003. Why did p53 gene therapy fail in ovarian cancer? Lancet Oncol. 4, 415-422. https://doi.org/10.1016/S1470-2045(03)01139-2
- Zeimet, A.G., E. Müller-Holzner, A. Schuler, G. Hartung, J. Berger, M. Hermann, M. Widschwendter, J.M. Bergelson, and C. Marth. 2002. Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas. Gene Ther. 9, 1093-1100. https://doi.org/10.1038/sj.gt.3301775